FDA Approves CytexOrtho Hip Human Clinical Trials

CytexOrtho ReNew Hip Implant

FDA approved a Phase I clinical trial, allowing CytexOrtho to initiate a first-in-human clinical study to evaluate the safety and efficacy of its ReNew Hip Implant novel cartilage repair technology.

The proprietary ReNew Hip Implant leverages advanced manufacturing techniques to create a highly porous, bioabsorbable device engineered to mimic...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0